insights_auto
Why is ANW down 10,26%?
Dive Deeperchevron_right
ANW:FRA
Immuron Ltd
0,018 €
arrow_downward
-10,26%(-0,0020) 1D
14 ოქტ, 08:12:55 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANW...
Open
0,02 €
High
0,02 €
Low
0,02 €
Mkt. cap
9,53 მლნ.
Avg. vol.
904,00
Volume
0,00
52-wk high
0,04 €
52-wk low
0,01 €
No. of employees
8
Open
0,02 €
High
0,02 €
Low
0,02 €
Mkt. cap
9,53 მლნ.
Avg. vol.
904,00
Volume
0,00
52-wk high
0,04 €
52-wk low
0,01 €
No. of employees
8
News stories
From web sources and news partners
Stock Titan
·
1 დღის წინ
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
TipRanks
·
1 დღის წინ
Immuron advances Travelan after Phase 2 data published in Nature journal
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees8
Founded1994
HeadquartersBlackburn North, ვიქტორიას შტატი, ავსტრალია
Sector-
Websiteimmuron.com.au